103 related articles for article (PubMed ID: 29958881)
21. Detection of human kallikrein 4 in healthy and cancerous prostatic tissues by immunofluorometry and immunohistochemistry.
Obiezu CV; Soosaipillai A; Jung K; Stephan C; Scorilas A; Howarth DH; Diamandis EP
Clin Chem; 2002 Aug; 48(8):1232-40. PubMed ID: 12142379
[TBL] [Abstract][Full Text] [Related]
22. Kallikrein 4 is a proliferative factor that is overexpressed in prostate cancer.
Klokk TI; Kilander A; Xi Z; Waehre H; Risberg B; Danielsen HE; Saatcioglu F
Cancer Res; 2007 Jun; 67(11):5221-30. PubMed ID: 17545602
[TBL] [Abstract][Full Text] [Related]
23. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer.
Borgoño CA; Grass L; Soosaipillai A; Yousef GM; Petraki CD; Howarth DH; Fracchioli S; Katsaros D; Diamandis EP
Cancer Res; 2003 Dec; 63(24):9032-41. PubMed ID: 14695222
[TBL] [Abstract][Full Text] [Related]
24. A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival.
Batra J; Nagle CM; O'Mara T; Higgins M; Dong Y; Tan OL; Lose F; Skeie LM; Srinivasan S; Bolton KL; Song H; Ramus SJ; Gayther SA; Pharoah PD; Kedda MA; Spurdle AB; Clements JA
BMC Cancer; 2011 Apr; 11():119. PubMed ID: 21457553
[TBL] [Abstract][Full Text] [Related]
25. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
Charlesworth MC; Young CY; Miller VM; Tindall DJ
J Androl; 1999; 20(2):220-9. PubMed ID: 10232657
[TBL] [Abstract][Full Text] [Related]
26. Epithelial-mesenchymal transition in prostate cancer and the potential role of kallikrein serine proteases.
Lawrence MG; Veveris-Lowe TL; Whitbread AK; Nicol DL; Clements JA
Cells Tissues Organs; 2007; 185(1-3):111-5. PubMed ID: 17587816
[TBL] [Abstract][Full Text] [Related]
27. Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms.
Dong Y; Bui LT; Odorico DM; Tan OL; Myers SA; Samaratunga H; Gardiner RA; Clements JA
Endocr Relat Cancer; 2005 Dec; 12(4):875-89. PubMed ID: 16322328
[TBL] [Abstract][Full Text] [Related]
28. Expression of human glandular kallikrein, hK2, in mammalian cells.
Kumar A; Goel AS; Hill TM; Mikolajczyk SD; Millar LS; Kuus-Reichel K; Saedi MS
Cancer Res; 1996 Dec; 56(23):5397-402. PubMed ID: 8968092
[TBL] [Abstract][Full Text] [Related]
29. The expanded human kallikrein (KLK) gene family: genomic organisation, tissue-specific expression and potential functions.
Clements J; Hooper J; Dong Y; Harvey T
Biol Chem; 2001 Jan; 382(1):5-14. PubMed ID: 11258672
[TBL] [Abstract][Full Text] [Related]
30. Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus.
Lawrence MG; Lai J; Clements JA
Endocr Rev; 2010 Aug; 31(4):407-46. PubMed ID: 20103546
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of human tissue kallikrein-related peptidases 11 and 15 in gastric cancer.
Kolin DL; Sy K; Rotondo F; Bassily MN; Kovacs K; Brezden-Masley C; Streutker CJ; Yousef GM
Tumour Biol; 2016 Jan; 37(1):437-46. PubMed ID: 26224476
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.
Sidiropoulos M; Pampalakis G; Sotiropoulou G; Katsaros D; Diamandis EP
Tumour Biol; 2005; 26(6):324-36. PubMed ID: 16254462
[TBL] [Abstract][Full Text] [Related]
33. Tissue kallikrein of human seminal plasma is secreted by the prostate gland.
Fink E; Schill WB; Fiedler F; Krassnigg F; Geiger R; Shimamoto K
Biol Chem Hoppe Seyler; 1985 Sep; 366(9):917-24. PubMed ID: 3852682
[TBL] [Abstract][Full Text] [Related]
34. Human tissue kallikrein gene family: applications in cancer.
Obiezu CV; Diamandis EP
Cancer Lett; 2005 Jun; 224(1):1-22. PubMed ID: 15911097
[TBL] [Abstract][Full Text] [Related]
35. Human kallikrein 4: quantitative study in tissues and evidence for its secretion into biological fluids.
Obiezu CV; Shan SJ; Soosaipillai A; Luo LY; Grass L; Sotiropoulou G; Petraki CD; Papanastasiou PA; Levesque MA; Diamandis EP
Clin Chem; 2005 Aug; 51(8):1432-42. PubMed ID: 15961548
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of kallikrein-related peptidase-4 in oral cancer.
Papagerakis P; Pannone G; Zheng LI; Athanassiou-Papaefthymiou M; Yamakoshi Y; McGuff HS; Shkeir O; Ghirtis K; Papagerakis S
Anticancer Res; 2015 Apr; 35(4):1861-6. PubMed ID: 25862839
[TBL] [Abstract][Full Text] [Related]
37. Human tissue kallikrein 9: production of recombinant proteins and specific antibodies.
Memari N; Grass L; Nakamura T; Karakucuk I; Diamandis EP
Biol Chem; 2006 Jun; 387(6):733-40. PubMed ID: 16800734
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical localization and analysis of kallikrein-related peptidase 7 and 11 expression in paired cancer and benign foci in prostate cancer patients.
Jamaspishvili T; Scorilas A; Kral M; Khomeriki I; Kurfurstova D; Kolar Z; Bouchal J
Neoplasma; 2011; 58(4):298-303. PubMed ID: 21520985
[TBL] [Abstract][Full Text] [Related]
39. Treatment of PC3 prostate cancer cells with mitoxantrone, etoposide, doxorubicin and carboplatin induces distinct alterations in the expression of kallikreins 5 and 11.
Thomadaki H; Mavridis K; Talieri M; Scorilas A
Thromb Haemost; 2009 Feb; 101(2):373-80. PubMed ID: 19190824
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues.
Yousef GM; Scorilas A; Chang A; Rendl L; Diamandis M; Jung K; Diamandis EP
Prostate; 2002 May; 51(2):126-32. PubMed ID: 11948967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
